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SIGNIFICANCE
This study evaluated 165 consecutive well-documented 
dermoscopic images, with the aim of illustrating the cha-
racteristics of a dermoscopic structure similar to blotches, 
but smaller (termed microblotches), and to evaluate their 
association with other dermoscopic structures. After eva-
luation by expert dermatoscopists, microblotches were de-
fined as superficial millimetric structures with geographical 
borders, only visible under dermoscopy. The study also 
evaluated 241 consecutive naevi from the HAM10000 da-
tabase and found that microblotches were present in only 
6.7% of naevi cases, compared with 38.7% of cases of me-
lanoma in our cohort (odds ratio; OR 5.79). Moreover, mi-
croblotches were more frequently observed in invasive me-
lanoma (OR 2.92), and their presence was associated with 
other dermoscopic criteria of poor prognosis. Histologically, 
they are correlated with hyperpigmented parakeratosis or 
consumption of the epidermis. In conclusion, microblot-
ches are correlated with invasive pigmented melanomas.
Numerous dermoscopic structures for the early de-
tection of melanoma have been described. The aim of 
this study was to illustrate the characteristics of der-
moscopic structures that are similar to blotches, but 
smaller (termed microblotches), and to evaluate their 
association with other well-known dermoscopic struc-
tures. A cross-sectional study design, including 165 
dermoscopic images of melanoma was used to define 
microblotches, and 241 consecutive images of naevi 
from the HAM10000 database, were studied to eva-
luate the prevalence of this criterion in both groups. 
Microblotches were defined as sharply demarcated 
structures ≤1 mm, with geographical borders visible 
only with dermoscopy. Microblotches were present 
in 38.7% of the melanomas and 6.7% of the naevi. 
More over, microblotches were associated with an odds 
ratio (OR) of malignancy of 5.79, and were more fre-
quent in invasive melanoma than in the in-situ subtype 
(OR 2.92). Histologically, they correspond to hyperpig-
mented parakeratosis or epidermal consumption. In 
conclusion, microblotches are related to melanomas. 
This finding could help dermatologists to differentiate 
between naevi and melanomas.
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Dermoscopy is an essential technique in the daily practice of dermatologists, which enables the identi-
fication of multiple patterns and structures of melanocytic 
lesions in order to differentiate early melanomas from 
benign melanocytic lesions (1). Since the introduction of 
dermoscopy, it has been possible to reduce the number 
of unnecessary excisions and biopsies (2, 3). 
In addition, dermoscopy has enabled the detection of 
certain features of invasive melanoma that correlate with 
a worse outcome of the disease (4–6). For example, the 
presence of blotches, absence of an atypical pigmented 
network, and the presence of microulceration has been 
associated with a positive sentinel lymph node biopsy 
(4). Furthermore, dermoscopy could help physicians to 
differentiate naevus-associated from de novo melanomas 
(7, 8). 
The primary objectives of this study were to describe 
the dermoscopic characteristics of microblotches and 
to evaluate their association with patients’ clinical cha-
racteristics, with other dermoscopic criteria, and with 
histological features of the tumour. 
MATERIALS AND METHODS
A single-centre cross-sectional study on patients diagnosed with 
melanoma from January 2014 to June 2015 in the Melanoma Unit 
of Hospital Clinic, Barcelona. As inclusion criteria, only lesions 
with histopathological diagnosis of in situ melanoma or invasive 
melanoma were examined. Dermoscopy images were obtained 
with a Dermlite Foto (3GEN, LLC, Dana Point, CA, USA), and 
clinical images using a Canon PowerShot G7 camera (Canon 
Inc., Japan). In all the tumours, patients’ clinical variables, such 
as age, sex, phototype, and location of the tumour, were recorded. 
Assessment of lesions and definition of microblotches
A total of 165 well-documented dermoscopic images of melanoma 
cases were evaluated by 2 expert dermatoscopists (SPu, JM) and 
2 dermatologists in training (SPo, NF). Evaluators were asked to 
indicate whether the new criterion of microblotches was present or 
absent, and whether 3 or more observers agreed that the presence 
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of microblotches was recognized. Furthermore, 
the prevalence of this criterion was evaluated in 
241 consecutive cases of naevus extracted from 
the HAM10000 database (9), in order to determine 
whether microblotches were present in normal naevi. 
After evaluation of all images, microblotches 
were described as millimetric (usually less than 
1 mm), well-defined structures with geographical 
borders, without visible dermoscopic structures in 
their interior. They may be different colours (black, 
light-brown, dark-brown, or display reddish tones), 
only visible with dermoscopy, and are seen more 
clearly with the application of immersion fluid. It 
was observed that microblotches are usually located 
in areas of higher pigmentation, and can be located 
both in the centre and the periphery of the tumour 
(Figs 1 and 2). Histopathological analysis revealed 
that they are correlated with 2 different conditions: 
epidermal thinning by the consumption of superficial 
layers of the epidermis; and/or presence of focal 
pigmented parakeratosis (Fig. 2). Interestingly, mi-
croblotches were not seen in amelanotic melanomas; 
however, there were only 9 (3.6%) of this subtype 
of melanoma in this series. 
During evaluation of the images, similarities to 
other dermoscopic structures, such as clods (glo-
bules/dots) and follicular plugs, were observed; 
however, microblotches differ from these structures 
because of their smaller size, geographical morpho-
logy and well-demarcated borders (Fig. 3). 
Fig. 1. (a, b, d, e) Dermoscopic examples and (c, f) diagrams of microblotches. Note the 
well-defined geographical aspect of their morphology and borders. 
Fig. 2. Microblotches. Examples of (a, b) microblotches and histopathological correlation with areas of: (c) consumption of superficial layers of the 
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Statistical analysis 
Pearson’s χ2 test was used to evaluate the association between 
categorical variables. If the expected frequency was < 5, Fisher’s 
exact test was used (Table I). The 95% confidence intervals (CIs) 
were obtained by the exact binomial method, and the overall risk 
(OR) calculated with a 95% CI. Statistical analyses were perfor-
med using the computing environment R and RStudio (10, 11). 
p-values < 0.05 were considered significant.
Interobserver analysis
A tutorial was prepared with the definition and examples of 
dermoscopic images of microblotches, in which 26 images were 
included (15 positives for these structures). In order to calculate 
the inter-rater reliability, a validity set of 30 images was assembled 
and given to the 3 independent observers (AB, CC, MC). Fleiss’s 
kappa method was used to evaluate the kappa index, since there 
were more than 2 independent observers. Interobserver analysis 
showed a kappa value of 0.794, which indicates substantial agree-
ment between observers.
RESULTS 
Of the 165 patients, 81 were male (49.1%) and 84 female 
(50.9%), with a mean age of 66 years, interquartile range 
54–80. Baseline characteristics of the patients with me-
lanoma included in the study are summarized in Table I. 
Microblotches were present in 46 melanomas, and were 
more frequent in invasive melanoma (39%, n = 31/80) 
than in in situ melanoma (18%, n = 15/85). The presence 
of microblotches was correlated with a 2.92-fold (95% 
CI 1.44–6.14; p = 0.003) increased risk of invasive me-
lanoma compared with in situ melanomas.
Furthermore, 241 consecutive cases from the HAM10000 
database were analysed, and a prevalence of 6.7% of 
microblotches was found, which were mainly present 
in more atypical dermoscopic lesions. Moreover, the 
presence of microblotches was associated with an odds 
ratio (OR) of 5.79 (95% CI 3.11–10.82) of having a 
melanoma compared with the naevus database. 
As for dermoscopic global patterns of melanomas 
that presented microblotches, the most frequent were 
the multicomponent pattern in 38 cases (82.6%) and the 
reticular pattern in 30 (65.2%). Furthermore, microblot-
ches were significantly associated with the presence of 
other dermoscopic features: in 43.5% of the cases with 
shiny white streaks (OR 3.45), 54.3% with blue-white 
veil (OR 7.67), 60.9% with regression (OR 2.73), 63% 
with atypical network (OR 3.12), 76.1% with atypical 
dots/globules (OR 5.53) and 23.9% of the cases with 
pseudopods (OR 3.89) (Table II).
DISCUSSION 
These results indicate that the presence of microblotches is 
highly indicative of malignancy, and is more common in 
invasive melanoma than in in situ melanoma. Furthermore, 
the presence of microblotches is associated with other der-
moscopic criteria of poor prognosis, such as shiny white 
streaks, blue-white veil, regression, atypical network, 
atypical dots and globules, and pseudopods. Shiny white 
streaks, well-described structures associated with inva-
sive melanomas and thicker tumours, appear to be due to 
changes in the dermal collagen (12), while microblotches 
provide information about epidermal changes, and both 
provide complementary biological prognostic information. 
Fig. 3. Possible errors in interpretation of microblotches. (a) Globules and (b) follicular plugs are round or oval with diffused regular edges; (c) 
blotches are larger than microblotches, usually with ill-defined borders.
Table I. Baseline characteristics of melanoma cases (n = 165)
Characteristics
Age, years, median (interquartile range) 66.00 (54.00, 79.00)
Sex, n (%)
 Female 81 (49.1)
 Male 84 (50.9)
Phototype, n (%)
  I 30 (18.5)
  II 95 (58.6)
  III 37 (22.8)
  Missing values, n 3
Location, n (%)
  Trunk 69 (41.8)
  Lower limb 39 (23.6)
  Head and neck 39 (23.6)
  Upper limb 17 (10.3)
  Acral 1 (0.6)
Subtype, n (%)
  In-situ 85 (51.5)
  Superficial spreading 59 (35.8)
  Lentigo maligna 9 (5.5)
  Acral lentiginous 8 (4.8)
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The literature contains several confusing dermoscopic 
terms (13); therefore, we suggest using the term “micro-
blotches”, because it does not presuppose the diagnosis 
of the lesion (superficial basal cell carcinoma for micro-
erosions) and does not use histopathological terminology 
(such as pigmented parakeratosis). The term can be used 
independently of the nature of the lesion. Furthermore, 
we believe that the presence of this structure could help 
dermatologists to suspect early invasive melanomas. 
The idea of microblotches arises from clinical observa-
tions in our centre, and with the aim of improving the 
morphological characterization of melanomas to better 
understand their biology. In daily practice, this criterion 
has helped us to decide to carry out further studies (e.g. 
confocal microscopy), resulting in the excision of the 
lesion and diagnosis of melanoma. 
The main limitation of this study is the difficulty of 
performing a histopathological correlation, due to the 
small size of the structure, which can easily be missed 
in some histopathological evaluations. With increasing 
use of artificial intelligence (AI) for image recognition, 
better criteria to identify suspicious lesions will probably 
be developed. Nevertheless, until new algorithms are 
fully developed and widely available for the dermato-
logy community, it is important to continue working 
on clinical dermoscopy criteria that can be used by all 
dermatologists.
Further studies are needed to determine whether mi-
croblotches constitute a prognostic factor or influence 
the survival of patients.
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Table II. Association of microblotches with dermoscopic and 






n (%) Odds ratio p-value
Histological subtype
  In-situ 70 (58.8) 15 (32.6) Ref. Ref.
  Invasive 49 (41.2) 31 (67.4) 2.92 [1.44; 6.14] 0.003
Patterns
  Reticular pattern 52 (43.7) 30 (65.2) 2.39 [1.19; 4.97] 0.014
  Globular pattern 18 (15.1)   6 (13.0) 0.86 [0.29; 2.23] 0.758
  Cobblestone pattern 119 (100) 46 (100) NC NC
  Homogeneous pattern 40 (33.6) 21 (45.7) 1.65 [0.82; 3.33] 0.159
  Starburst pattern   1 (0.84)   3 (6.52) 7.47 [0.84; 218] 0.072
  Non-specific pattern 54 (45.4) 20 (43.5) 0.93 [0.46; 1.84] 0.830
  Parallel pattern   3 (2.52)   1 (2.17) 0.93 [0.03; 8.28] 0.956
  Multicomponent 
pattern
47 (39.5) 38 (82.6) 7.09 [3.17; 17.8] < 0.001
Structures
  Shiny white streaks 16 (13.4) 20 (43.5) 4.88 [2.23; 10.9] < 0.001
  Rosettes 119 (100) 46 (100) NC NC
  Blue-white veil 14 (11.8) 25 (54.3) 8.72 [3.95; 20.1] < 0.001
  Peppering 18 (15.1)   9 (19.6) 1.37 [0.54; 3.28] 0.494
  Regression 40 (33.6) 28 (60.9) 3.04 [1.51; 6.26] 0.002
  Dotted vessels 13 (10.9)   4 (8.70) 0.80 [0.21; 2.43] 0.705
  Polymorphic vessels 30 (25.2) 12 (26.1) 1.05 [0.47; 2.27] 0.899
  Corkscrew vessels   4 (3.36)   0 (0.00) NC NC
  Milky red areas 30 (25.2)   9 (19.6) 0.73 [0.30; 1.65] 0.458
  Typical network 22 (18.5)   6 (13.0) 0.67 [0.23; 1.71] 0.420
  Atypical network 46 (38.7) 29 (63.0) 2.68 [1.34; 5.53] 0.005
  Pseudo-network 14 (11.8)   7 (15.2) 1.36 [0.48; 3.56] 0.553
  Typical dots – globules   2 (1.68)   4 (8.70) 5.32 [0.94; 44.3] 0.058
  Atypical dots – globules 61 (51.3) 35 (76.1) 2.98 [1.41; 6.71] 0.004
  Pseudopods   9 (7.56) 11 (23.9) 3.79 [1.44; 10.3] 0.007
  Structureless 
homogeneous 
pigmentation
34 (28.6) 17 (37.0) 1.46 [0.70; 3.01] 0.305
  Negative pigment 
network
  5 (4.20)   2 (4.35) 1.08 [0.13; 5.46] 0.932
  Asymmetrical 
pigmented follicular 
openings
19 (16.0)   7 (15.2) 0.96 [0.35; 2.39] 0.926
Values in bold have a significant association with microblotches. NC: not calculable.
